TLDR Hair cortisol concentration partly reflects HPA axis regulation but doesn't capture all its complexities.
This study investigates whether hair cortisol concentration (HCC) can reflect the regulatory biology of the HPA axis in healthy humans. The research involved healthy participants who provided hair samples over a 1-month period and underwent various HPA regulatory assessments. The study found that 23% of the variance in HCC could be predicted by factors such as feedback inhibition (8.7%), adrenal sensitivity (8%), and stress reactivity. The findings suggest that while HCC is a useful indicator of stress-related health outcomes, it does not fully capture the complex regulatory changes of the HPA axis. The study highlights the need for further research to understand the mechanistic pathways that shape HCC and its relevance to stress and health.
1 citations
,
July 2023 in “Psychoneuroendocrinology” Hair cortisol is a reliable marker of long-term cortisol levels and is linked to daytime saliva cortisol but not morning levels.
501 citations
,
October 2008 in “Psychoneuroendocrinology” Hair cortisol levels can show increased stress during late pregnancy but only for up to six months.
489 citations
,
June 2005 in “The FASEB Journal” Human hair follicles can produce cortisol like the body's stress response system.
42 citations
,
March 2008 in “Molecular and Cellular Endocrinology” Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.
87 citations
,
December 2015 in “Cochrane library” No single treatment is clearly effective for central serous chorioretinopathy.
47 citations
,
February 2015 in “European Journal of Clinical Investigation” The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.
20 citations
,
November 2019 in “Biomolecules” Finasteride reduces response to stress and rewards, affecting behavior and mental health.
December 2016 in “Springer eBooks” Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.
